When COVID-19 first began to spread, governments across the world didn’t have much of a clue as to what the best treatment would be.
Fox News host Tucker Carlson, along with his colleague Laura Ingraham, were some of the first media personalities in the U.S. to bring on guests claiming that the anti-malarial drugs hydroxychloroquine and azithromycin were helping people infected with the virus.
President Donald Trump, an avid Fox viewer, must have been watching.
During a news conference at the White House last week, Trump touted the drug combination as a possible cure despite Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, saying there was only “anecdotal” evidence to suggest that they are.
HYDROXYCHLOROQUINE & AZITHROMYCIN, taken together, have a real chance to be one of the biggest game changers in the history of medicine. The FDA has moved mountains – Thank You! Hopefully they will BOTH (H works better with A, International Journal of Antimicrobial Agents)…..
— Donald J. Trump (@realDonaldTrump) March 21, 2020
After the president endorsed the drugs, the anti-Trump corporate media instantly leapt into action to discredit him.
CNN ran an “analysis” piece with the headline “Trump peddles unsubstantiated hope in dark times.”
NBC reporter Peter Alexander asked Trump whether he was giving “false hope” to people infected with COVID-19 by expressing his support for hydroxychloroquine and azithromycin.
The New Yorker ran two articles accusing the president of pushing bogus science.
One article was titled, “Trump’s Dangerous Messaging About a Possible Coronavirus Treatment.” The other, “The Meaning of Donald Trump’s Coronavirus Quackery.”
Meanwhile, Twitter took down a Rudy Giuliani tweet that said hydroxychloroquine was a possible way to treat the virus.
On Sunday, the Department of Health and Human Services announced it has accepted 30 million doses of hydroxychloroquine sulfate and one million doses of chloroquine phosphate from a pair of pharmaceutical companies in order to treat patients hospitalized by COVID-19.
The HHS statement explained that the Food and Drug Administration had issued an “emergency use authorization” so the drugs can be distributed and prescribed by doctors to hospitalized teen and adult patients with coronavirus when a clinical trial is not available or feasible.
Hydroxychloroquine, as President Trump suggested, is an important development in treating patients with the coronavirus.https://t.co/4cpWJw73Gh
— newtgingrich (@newtgingrich) March 30, 2020
This is a game changer in the fight against COVID-19, as there is mounting first-hand evidence the drug is indeed an effective way to cure those who are suffering from the virus.
One such case is a Michigan man who said hydroxychloroquine and azithromycin cured him from his symptoms. Laura Cox, the chairwomen of the Michigan Republican Party, shared his story on Twitter.
Amazing news out of Michigan!
Jim Santilli, of Macomb County, says Hydroxychloroquine, Azithromycin saved him.
— Laura Cox (@MIGOPChair) March 31, 2020
Democratic Gov. Gretchen Whitmer has already requested access to the HHS stockpile so other COVID-19 patients in her state can be prescribed them.
— The Detroit News (@detroitnews) March 31, 2020
Margaret Novins, a woman in her 50s from New Jersey, also improved after taking hydroxychloroquine. Her story was covered in Forbes.
Dr. Vladimir Zelenko of New York allegedly has a 100 percent cure rate with the drugs.
#coronavirus News Alert: Dr. Vladimir Zelenko, a board-certified family practitioner in NY, has now treated 699 Covid-19 patients with 100% success using Hydroxychloroquine Sulfate, Zinc and Z-Pak. All symptoms of shortness of breath resolved within 4-6 hr https://t.co/siCvNg845Q pic.twitter.com/lOrUvBHp0A
— Adam Milstein (@AdamMilstein) March 29, 2020
But the Trump Derangement Syndrome-infected media continues to push back.
The Guardian published an article with the headline “Trump touted hydroxychloroquine as a cure for Covid-19. Don’t believe the hype.”
Politico took a swipe at Ingraham.
Earlier this month, Fox News host Laura Ingraham tweeted praise for hydroxychloroquine, an anti-malaria drug championed by President Trump as a potential treatment for the virus, despite little evidence to that effecthttps://t.co/k4A7Mc9Hp7
— POLITICO (@politico) March 31, 2020
CNN again emphasized that there is “little scientific evidence” behind the claim that these drugs are effective in treating coronavirus.
Why does CNN not recognize the COVID patients all over the world who have walked out of hospitals testing negative after being treated with hydroxychloroquine? https://t.co/yiuGQ9TyB2
— Laura Ingraham (@IngrahamAngle) March 30, 2020
It seems as though the corporate media would rather people die than give Trump an ounce of credit for pushing hydroxychloroquine and azithromycin as a possible cure to the COVID-19 virus.
Carlson said it best when in a monologue last week he explained that the real reason the media is taking such a negative approach to the possible cure is quite simple — the president supports it.
“At the very least we should all be following developments in hydroxychloroquine’s use with interest and measured hope. Why wouldn’t we be?” he asked.
“Well,” he continued, “here’s why: Donald Trump is for it.”
“Several days ago, the president expressed confidence in hydroxychloroquine as a treatment for the epidemic. That was it for the media. If Trump is for it, they’re against it, even if it might save American lives. What reactive children they are. And they immediately began a sustained push to discredit the drug long before the clinical results were in.”
.@DrMarcSiegel gives a “shout-out” to Tucker Carlson for bringing attention to hydroxychloroquine as a potential coronavirus treatment:
“I believe our focus on this drug has led directly to FDA emergency approval, which may save many lives.” pic.twitter.com/LBuZkgDe42
— Scott Morefield (@SKMorefield) March 31, 2020
It sure seems Tucker is going to have the last laugh on this one.
Truth and Accuracy
We are committed to truth and accuracy in all of our journalism. Read our editorial standards.